AAAAAA

   
Results: 1-25 | 26-50 | 51-58 |
Results: 51-58/58
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA - CLINICAL-RESULTS AND RISK-FACTORS IN 70 PATIENTS
Authors: TOMAS JF PENARRUBIA MJ GARCIA JA FIGUERA A DESORIA VGG STEEGMANN JL ARRANZ R CAMARA R GABRIEL R VAZQUEZ L FERNANDEZRANADA JM
Citation: Jf. Tomas et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA - CLINICAL-RESULTS AND RISK-FACTORS IN 70 PATIENTS, Medicina Clinica, 105(16), 1995, pp. 605-611
HEMATOPOIETIC PROGENITOR TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA - WHY, WHEN AND HOW
Authors: TOMAS JF FERNANDEZRANADA JM
Citation: Jf. Tomas et Jm. Fernandezranada, HEMATOPOIETIC PROGENITOR TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA - WHY, WHEN AND HOW, Medicina Clinica, 104(17), 1995, pp. 653-655
BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
Authors: ALEGRE A LAMANA M ARRANZ R FERNANDEZVILLALTA MJ TOMAS JF FIGUERA A CAMARA R STEEGMAN JL CASADO F REQUENA MJ PLANAS JL VAZQUEZ L GRANDA A FERNANDEZRANADA JM
Citation: A. Alegre et al., BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA, British Journal of Haematology, 91(2), 1995, pp. 380-386
HIGH-DOSE CYCLOPHOSPHAMIDE PLUS GM-CSF VERSUS G-CSF ALONE TO MOBILIZEPBSCS FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA
Authors: ALEGRE A TOMAS LF ESCUDERO A GILFERNANDEZ JL ARRANZ R GRANDA A LOPEZPASCUAL K LOPEZ JL PINILLA I FERNANDEZRANADA JM
Citation: A. Alegre et al., HIGH-DOSE CYCLOPHOSPHAMIDE PLUS GM-CSF VERSUS G-CSF ALONE TO MOBILIZEPBSCS FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA, Blood, 86(10), 1995, pp. 3733-3733
ALL-TRANS-RETINOIC ACID TREATMENT AND SWEET SYNDROME
Authors: TOMAS JF ESCUDERO A FERNANDEZRANADA JM
Citation: Jf. Tomas et al., ALL-TRANS-RETINOIC ACID TREATMENT AND SWEET SYNDROME, Leukemia, 8(9), 1994, pp. 1596-1596
ERYTHROPOIETIN IN THE TREATMENT OF DELAYED IMMUNE HEMOLYSIS OF A MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANT
Authors: LOPEZ J STEEGMANN JL PEREZ G OTERO MJ BERBERANA M CAMARA R LAMANA M VILLALTA MJF FERNANDEZRANADA JM
Citation: J. Lopez et al., ERYTHROPOIETIN IN THE TREATMENT OF DELAYED IMMUNE HEMOLYSIS OF A MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANT, American journal of hematology, 45(3), 1994, pp. 237-239
ERYTHROPOIETIN TREATMENT AND PLATELET RECONSTITUTION IN BONE-MARROW TRANSPLANTATION
Authors: STEEGMANN JL CASADO F LOPEZ J FERNANDEZRANADA JM
Citation: Jl. Steegmann et al., ERYTHROPOIETIN TREATMENT AND PLATELET RECONSTITUTION IN BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 88(3), 1994, pp. 662-662
INTERFERON ALPHA-2A IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - RESULTS OF THE SPANISH GROUP
Authors: FERNANDEZRANADA JM LAVILLA E ODRIOZOLA J GARCIALARANA J LOZANO M PARODY R GIRALDO MP CARBONELL F FERRO MT STEEGMANN JL
Citation: Jm. Fernandezranada et al., INTERFERON ALPHA-2A IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - RESULTS OF THE SPANISH GROUP, Leukemia & lymphoma, 11, 1993, pp. 175-179
Risultati: 1-25 | 26-50 | 51-58 |